-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2023 to 2024.
- Neuphoria Therapeutics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$3.7M, a 18.7% increase year-over-year.
- Neuphoria Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$17.9M, a 18.6% increase from 2023.
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)